CORPORATE GOVERNANCE | 2026-07-10
Delaware Chancery Dismisses Alcon Derivative Suit: Governance Lessons
Chancellor McCormick's full dismissal of the roughly 700 million dollar Rostov v. Alcon derivative action delivers pointed fiduciary-duty and special-committee guidance for the many California venture-backed startups, biotechnology firms, and technology companies that operate in the state yet incorporate in Delaware.
By Anatolii Trembach, Esq. (California State Bar No. 349304; LL.M., USC Gould School of Law; admitted to the U.S. Court of International Trade), Trembach Law Firm, APC · Published
On June 26, 2026, the Delaware Court of Chancery handed down a decision that should command the attention of every California founder, board member, and venture investor whose company is incorporated in Delaware. In Rostov v. Alcon Research, LLC, Chancellor Kathaleen St. J. McCormick dismissed in full a six-count derivative action that sought approximately 700 million dollars in damages arising from a bitter, multi-year control contest inside Aurion Biotech, Inc., a life-sciences company develop
Contact Trembach Law Firm at (818) 514-7680 for a confidential consultation.
Trembach Law Firm | 27001 Agoura Road, Suite 350, Calabasas, CA 91301